BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23247208)

  • 1. Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy.
    Blanco-García RM; López-Álvarez MR; Garrido IP; Salgado-Cecilia G; Campillo JA; Bolarín JM; Gimeno L; Muro M; García-Alonso AM; Martínez-Sánchez MV; Bernardo Pisa MV; Soriano-Díaz S; Pascual-Figal DA; Alvarez-López MR; Minguela A
    Hum Immunol; 2013 Mar; 74(3):318-24. PubMed ID: 23247208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative myocardial contrast echocardiography: a new method for the non-invasive detection of chronic heart transplant rejection.
    Rutz T; de Marchi SF; Roelli P; Gloekler S; Traupe T; Steck H; Eshtehardi P; Cook S; Vogel R; Mohacsi P; Seiler C
    Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1187-94. PubMed ID: 23612502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients.
    Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D
    Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study.
    Mehra MR; Ventura HO; Chambers R; Collins TJ; Ramee SR; Kates MA; Smart FW; Stapleton DD
    J Am Coll Cardiol; 1995 Nov; 26(6):1537-44. PubMed ID: 7594082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of HLA-G expression in serum and biopsy samples of kidney transplant recipients.
    Poláková K; Bandžuchová H; Žilinská Z; Chreňová S; Kuba D; Russ G
    Immunobiology; 2015 Apr; 220(4):533-7. PubMed ID: 25468563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.
    Tu W; Potena L; Stepick-Biek P; Liu L; Dionis KY; Luikart H; Fearon WF; Holmes TH; Chin C; Cooke JP; Valantine HA; Mocarski ES; Lewis DB
    Circulation; 2006 Oct; 114(15):1608-15. PubMed ID: 17015794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD28 and KIR2D receptors as sensors of the immune status in heart and liver transplantation.
    Blanco-García RM; López-Álvarez MR; Garrido IP; Salgado-Cecilia G; Campillo JA; Bolarín JM; Legaz I; Muro M; García-Alonso AM; Martínez-Sánchez MV; Moral JM; Pascual-Figal DA; Alvarez-López MR; Miras M; Minguela A
    Hum Immunol; 2011 Oct; 72(10):841-8. PubMed ID: 21742001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum soluble HLA-G, soluble CD30 is correlated to the time after transplantation in renal transplant recipients].
    Jin Z; Xu C; Duan W; Yang J; Tian P
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Jul; 33(7):947-952. PubMed ID: 28712403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-G expression in the peripheral blood of live kidney transplant recipients.
    Xiao L; Zhou WQ; Shi BY; Feng K; He XY; Wei YX; Gao Y; Meng XY; Xiao W
    Chin Med J (Engl); 2013 Jul; 126(14):2652-5. PubMed ID: 23876890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against heterogeneous nuclear ribonucleoprotein K in patients with cardiac allograft vasculopathy.
    Acevedo MJ; Caro-Oleas JL; Álvarez-Márquez AJ; Sobrino JM; Lage-Gallé E; Aguilera I; Núñez-Roldán A
    J Heart Lung Transplant; 2011 Sep; 30(9):1051-9. PubMed ID: 21489814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Monitoring of cytomegalovirus-specific CD4+ and CD8+ T cell responses by cytokine flow cytometry in renal transplant recipients].
    Kılınçkaya Doğan H; Mutlu E; Köksoy S; Yılmaz VT; Koçak H; Çolak D; Mutlu D; Günseren F; Dinçkan A; Aliosmanoğlu İ; Süleymanlar G; Gültekin M
    Mikrobiyol Bul; 2016 Apr; 50(2):224-35. PubMed ID: 27175495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up study on the utility of von Willebrand factor levels in the diagnosis of cardiac allograft vasculopathy.
    Martínez-Dolz L; Almenar L; Reganon E; Vila V; Chamorro C; Andrés L; Martínez-Sales V; Moro J; Agüero J; Sánchez-Lázaro I; Salvador A
    J Heart Lung Transplant; 2008 Jul; 27(7):760-6. PubMed ID: 18582806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment and prophylaxis of cardiac allograft vasculopathy.
    Wang SS
    Transplant Proc; 2008 Oct; 40(8):2609-10. PubMed ID: 18929815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of recipient CD4+ but not CD8+ T lymphocytes prevents the development of cardiac allograft vasculopathy.
    Szeto WY; Krasinskas AM; Kreisel D; Krupnick AS; Popma SH; Rosengard BR
    Transplantation; 2002 Apr; 73(7):1116-22. PubMed ID: 11965043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a competitive enzyme-linked immunosorbent assay for measurements of soluble HLA-G protein.
    Rasmussen M; Dahl M; Buus S; Djurisic S; Ohlsson J; Hviid TV
    Tissue Antigens; 2014 Aug; 84(2):206-15. PubMed ID: 24785939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy.
    Nath DS; Ilias Basha H; Tiriveedhi V; Alur C; Phelan D; Ewald GA; Moazami N; Mohanakumar T
    J Heart Lung Transplant; 2010 Nov; 29(11):1277-85. PubMed ID: 20615726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of immunological markers with graft vasculopathy development in heart transplantation.
    Roldán C; Mirabet S; Brossa V; Moltó E; Lopez L; Alvaro Y; Sole E; Padró JM; Gelpí C; Roig E
    Transplant Proc; 2012 Nov; 44(9):2653-6. PubMed ID: 23146484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and characterization of time-related differences in plaque composition by intravascular ultrasound-derived radiofrequency analysis in heart transplant recipients.
    König A; Kilian E; Sohn HY; Rieber J; Schiele TM; Siebert U; Gothe RM; Reichart B; Klauss V
    J Heart Lung Transplant; 2008 Mar; 27(3):302-9. PubMed ID: 18342753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.